Patel Harshad MD is categorized under Specialty Outpatient Clinics, Nec in Greenville, PA and active since 2002.
Patel Harshad MD was established in 2002, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Specialty Outpatient Clinics, Nec business, which does work in the B2C market, and is classified as a Specialty Outpatient Clinics, Nec, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Harshad Patel at the company’s single location by writing to 348 Main St, Greenville, Pennsylvania PA 16125 or by phoning (724) 588-5250. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Patel Harshad MD |
| Contact Person: | Harshad Patel |
| Address: | 348 Main St, Greenville, Pennsylvania 16125 |
| Phone Number: | (724) 588-5250 |
| Website Address: | primary-health.net |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Specialty Outpatient Clinics, Nec |
| SIC Code: | 8093 |
| NAICS Code: | 6211110 |
| Share This Business: |
Patel Harshad MD was started in 2002 to provide professional Specialty Outpatient Clinics, Nec under the SIC code 8093 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Harshad Patel for inquiries that concern Patel Harshad MD by calling the company number (724) 588-5250, as your correspondence is most welcome. Additionally, the physical location of the single location of Patel Harshad MD can be found at the coordinates 41.40836,-80.37896 as well as the street address 348 Main St in Greenville, Pennsylvania 16125.
For its online presence, you may visit Patel Harshad MD’s website at primary-health.net and engage with its social media outlets through on Twitter and on Facebook.